https://doi.org/10.4081/monaldi.2006.573
Pulmonary Mycobacterium Simiae infection and HTLV1 infection: an incidental co-infection or a predisposing factor?
Submitted: February 12, 2016
Accepted: February 12, 2016
Published: February 15, 2016
Accepted: February 12, 2016
Abstract Views: 656
PDF: 438
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Mirsaeidi, S.M., P. Tabarsi, A. Mardanloo, G. Ebrahimi, M. Amiri, P. Farnia, M. Sheikhleslami, et al. 2016. “Pulmonary Mycobacterium Simiae Infection and HTLV1 Infection: An Incidental Co-Infection or a Predisposing Factor?”. Monaldi Archives for Chest Disease 65 (2). https://doi.org/10.4081/monaldi.2006.573.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Nicholas Zareifopoulos, Maria Lagadinou, Anastasia Karela, Christina Platanaki, Gerasimos Karantzogiannis, Dimitrios Velissaris, Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
You may also start an advanced similarity search for this article.
